نتائج البحث - "Cottafavi L."

1

Academic Journal

Perceptions of Death Among Patients with Advanced Cancer Receiving Early Palliative Care and Their Caregivers: Results from a Mixed-Method Analysis

المؤلفون: Bigi S., Ganfi V., Borelli E., Potenza L., Artioli F., Eliardo S., Mucciarini C., Cottafavi L., Ferrari U., Lombardo L., Cagossi K., Pietramaggiori A., Fantuzzi V., Bernardini I., Cruciani M., Cacciari C., Odejide O., Adolfo Porro C., Zimmermann C., Efficace F., Bruera E., Luppi M., Bandieri E.

المساهمون: Bigi, S., Ganfi, V., Borelli, E., Potenza, L., Artioli, F., Eliardo, S., Mucciarini, C., Cottafavi, L., Ferrari, U., Lombardo, L., Cagossi, K., Pietramaggiori, A., Fantuzzi, V., Bernardini, I., Cruciani, M., Cacciari, C., Odejide, O., Adolfo Porro, C., Zimmermann, C., Efficace, F., Bruera, E., Luppi, M., Bandieri, E.

مصطلحات موضوعية: advanced cancer, communication, death, early palliative care, qualitative research, terminal care

Relation: info:eu-repo/semantics/altIdentifier/pmid/36320128; info:eu-repo/semantics/altIdentifier/wos/WOS:000877747400001; volume:28; issue:1; firstpage:54; lastpage:62; journal:THE ONCOLOGIST; https://hdl.handle.net/11380/1296808; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85146531943

الاتاحة: https://hdl.handle.net/11380/1296808
https://doi.org/10.1093/oncolo/oyac227

View record in BASE

2

Academic Journal

The prognostic and predictive role of somatic brca mutations in ovarian cancer: Results from a multicenter cohort study

المؤلفون: Toss A., Piombino C., Tenedini E., Bologna A., Gasparini E., Tarantino V., Filieri M. E., Cottafavi L., Giovanardi F., Madrigali S., Civallero M., Marcheselli L., Marchi I., Domati F., Venturelli M., Barbieri E., Grandi G., Tagliafico E., Cortesi L.

المساهمون: Toss, A., Piombino, C., Tenedini, E., Bologna, A., Gasparini, E., Tarantino, V., Filieri, M. E., Cottafavi, L., Giovanardi, F., Madrigali, S., Civallero, M., Marcheselli, L., Marchi, I., Domati, F., Venturelli, M., Barbieri, E., Grandi, G., Tagliafico, E., Cortesi, L.

مصطلحات موضوعية: BRCA, Copy number variation, Genetic testing, Ovarian cancer

Relation: info:eu-repo/semantics/altIdentifier/pmid/33801055; info:eu-repo/semantics/altIdentifier/wos/WOS:000633602900001; volume:11; issue:3; firstpage:N/A; lastpage:N/A; journal:DIAGNOSTICS; http://hdl.handle.net/11380/1252137; info:eu-repo/semantics/altIdentifier/scopus/2-s2.0-85108998976

الاتاحة: http://hdl.handle.net/11380/1252137
https://doi.org/10.3390/diagnostics11030565

View record in BASE

3

Nine weeks versus 1 year adjuvant trastuzumab in combination with chemotherapy: final results of the phase III randomized Short-HER study

المؤلفون: Conte, P., Frassoldati, A., Bisagni, G., Brandes, A. A., Donadio, M., Garrone, O., Piacentini, F., Cavanna, L., Giotta, F., Aieta, M., Gebbia, V., Molino, A., Musolino, A., Ferro, A., Maltoni, R., Danese, S., Zamagni, C., Rimanti, A., Cagossi, K., Russo, A., Pronzato, P., Giovanardi, F., Moretti, G., Lombardo, L., Schirone, A., Beano, A., Amaducci, L., Bajardi, E. A., Vicini, R., Balduzzi, S., D'Amico, R., Guarneri, Falci C, V., Giarratano, T, Mcmahon, L, De Salvo GL, Dieci, Mv, Maiorana, A, Ficarra, G, Caggia, F, Grisolia, D, Bartolini, S, Lorusso, V, Ardito, R, Tartarone, A, Vanella, P, Taverniti, C, Porpiglia, M, Spanu, Pg, Biglia, N, Andreis, D, Piancastelli, A, Fedeli, A, Parra, Hs, Gambaro, Ar, Romito, S, Malossi, A, Gori, S, Miglietta, L, Del Mastro, L, Amoroso, D, Mansutti, M, Generali, D, Prati, G, Bertolini, A, Berardi, R, Zanni, A, Cottafavi, L, Bologna, A, Naso, G, Pancotti, A, Farci, D, Zoboli, A, Silva, R, Laudadio, L, Bordonaro, R, Marenco, D, Dongiovanni, V, Baldini, E, Saggia, C, Gorzegno, G, Cariello, A, Biganzoli, L, Rampello, E.

المساهمون: Conte P., Frassoldati A., Bisagni G., Brandes A.A., Donadio M., Garrone O., Piacentini F., Cavanna L., Giotta F., Aieta M., Gebbia V., Molino A., Musolino A., Ferro A., Maltoni R., Danese S., Zamagni C., Rimanti A., Cagossi K., Russo A., Pronzato P., Giovanardi F., Moretti G., Lombardo L., Schirone A., Beano A., Amaducci L., Bajardi E.A., Vicini R., Balduzzi S., D'Amico R., Guarneri V.

المصدر: Annals of Oncology. 29:2328-2333

مصطلحات موضوعية: Oncology, Time Factors, Adjuvant, Breast cancer, Cardiac safety, De-escalated treatment, Trastuzumab, Settore MED/06 - Oncologia Medica, Receptor, ErbB-2, medicine.medical_treatment, Anthracycline, 030204 cardiovascular system & hematology, Breast cancer, Antineoplastic Agents, Immunological, ErbB-2, 0302 clinical medicine, Trastuzumab, Antineoplastic Combined Chemotherapy Protocols, Clinical endpoint, Anthracyclines, skin and connective tissue diseases, Adjuvant, Mastectomy, Cardiac safety, De-escalated treatment, Hazard ratio, Hematology, Middle Aged, Chemotherapy regimen, Bridged-Ring Compound, Immunological, Local, Chemotherapy, Adjuvant, 030220 oncology & carcinogenesis, Female, Taxoids, Trastuzumab, adjuvant, breast cancer, cardiac safety, de-escalated treatment, Breast Neoplasm, Human, Receptor, medicine.drug, Adult, Bridged-Ring Compounds, medicine.medical_specialty, Time Factor, Socio-culturale, Breast Neoplasms, Antineoplastic Agents, Disease-Free Survival, Drug Administration Schedule, 03 medical and health sciences, Taxoid, Internal medicine, medicine, Humans, Chemotherapy, Risk factor, Aged, Neoplasm Staging, Antineoplastic Combined Chemotherapy Protocol, business.industry, medicine.disease, Cardiotoxicity, Neoplasm Recurrence, Neoplasm Recurrence, Local, business